Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

First-in-Human, Phase Ia , Dose Escalation, Monotherapy Study of QLS32015, a Novel GPRC5D×CD3 T-Cell Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Lu-Gui Qiu, Gang An, Baijun Fang, Xiaobing Huang, Yan Xu, Yuzhang Liu, Feifei Che, Xinai Yang, Xianlin Duan, Peng Shao, Xiaoyan Kang

Blood (2024) 144 (Supplement 1): 1990.

https://doi.org/10.1182/blood-2024-201960

Published: 2024

Journal Articles

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Blood (2024) 144 (Supplement 1): 4748.

https://doi.org/10.1182/blood-2024-202893

Published: 2024

Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Blood (2023) 142 (Supplement 1): 4951.

https://doi.org/10.1182/blood-2023-184407

Published: 2023

Journal Articles

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Xi Yang, Chenglong Li, Feifei Che, Hong Zheng, Jiao Chen, Xiaobing Huang

Blood (2022) 140 (Supplement 1): 12930.

https://doi.org/10.1182/blood-2022-168915

Published: 2022

Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai

Blood (2022) 140 (Supplement 1): 12439.

https://doi.org/10.1182/blood-2022-157665

Published: 2022

Journal Articles

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Xi Wang, Feifei Che, Wanjun Cao, Zichen Ye, Hong Zheng, Xiaobing Huang, Rong Xiao, Wen Wang, Xuemei Ye, Lin He, Jingying Dai

Blood (2021) 138 (Supplement 1): 4702.

https://doi.org/10.1182/blood-2021-146768

Published: 2021

Journal Articles

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Yu Wang, Xuemei Ye, Hong Zheng, Yan Mao, Xuemei Wang, Feifei Che, Chunsen Wang, Xi Yang, Xiaobing Huang

Blood (2021) 138 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2021-149569

Published: 2021

Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138462

Published: 2020

Journal Articles

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Jingying Dai, PhD, Hong Zheng, MD PhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD

Blood (2019) 134 (Supplement_1): 5376.

https://doi.org/10.1182/blood-2019-128413

Published: 2019

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang

Blood (2019) 134 (Supplement_1): 1966.

https://doi.org/10.1182/blood-2019-126632

Published: 2019

Journal Articles

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Jingying Dai, PhD, Xi Yang, Xiaobing Huang, Hong Zheng, MD PhD, Xiaodong Wang, MD

Blood (2018) 132 (Supplement 1): 4272.

https://doi.org/10.1182/blood-2018-99-113032

Published: 2018

Journal Articles

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

Xi Yang, Hong Zheng, MD PhD, Jingying Dai, PhD, Chenglong Li, MDand PhD, Rong Zhang, MD PhD, Xiaodong WANG, MD, Chunsen Wang, MD, Xiaobing Huang

Blood (2018) 132 (Supplement 1): 3424.

https://doi.org/10.1182/blood-2018-99-111671

Published: 2018

Journal Articles

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Xi Yang, Xiaobing Huang, MDand PhD, Hong Zheng, MDPhD, Chenglong Li, MDand PhD, Jingying Dai, PhD, Rong Zhang, MDand PhD, Xiaodong Wang, PhD, Chunsen Wang, MD

Blood (2017) 130 (Supplement 1): 3278.

https://doi.org/10.1182/blood.V130.Suppl_1.3278.3278

Published: 2017

Journal Articles

Sirolimus Is Effective in Refractory Immune Thrombocytopenia: Results of an Open-Label Prospective Multicenter Trial in China

Blood (2017) 130 (Supplement 1): 4728.

https://doi.org/10.1182/blood.V130.Suppl_1.4728.4728

Published: 2017

NARROW

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

First-in-Human, Phase Ia , Dose Escalation, Monotherapy Study of QLS32015, a Novel GPRC5D×CD3 T-Cell Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Single Center Experience of " Mobilize，Collect and Transplant, No Cryopreservation" Integrated Autologous Hematopoietic Stem Cells Transplantation Strategy for Newly Diagnosed Multiple Myeloma

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

High-Dose Intravenous Acyclovir Is Safe and Effective in the Treatment of EBV Reactivation Post Allogeneic Hematopoietic Stem Cell Transplantation

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Sirolimus Is Effective in Refractory Immune Thrombocytopenia: Results of an Open-Label Prospective Multicenter Trial in China

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only